72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes

, &
Pages 67-72 | Published online: 02 Apr 2012

References

  • BoltonKSegalDMcMillanJDecorin is a secreted protein associated with obesity and type 2 diabetesInt J Obes (Lond)20083271113112118414424
  • FisherLWTermineJDYoungMFDeduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of speciesJ Biol Chem19892648457145762647739
  • HildebrandARomarisMRasmussenLMInteraction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor betaBiochem J1994302Pt 25275348093006
  • SchonherrEWitsch-PrehmPHarrachBRobenekHRauterbergJKresseHInteraction of biglycan with type I collagenJ Biol Chem19952706277627837852349
  • BiYStueltenCHKiltsTExtracellular matrix proteoglycans control the fate of bone marrow stromal cellsJ Biol Chem200528034304813048915964849
  • YoungMFBiYAmeyeLChenXDBiglycan knockout mice: new models for musculoskeletal diseasesGlycoconj J2002194–525726212975603
  • WadhwaSBiYOrtizATImpaired posterior frontal sutural fusion in the biglycan/decorin double deficient miceBone200740486186617188951
  • DanielsonKGBaribaultHHolmesDFGrahamHKadlerKEIozzoRVTargeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragilityJ Cell Biol199713637297439024701
  • XuTBiancoPFisherLWTargeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in miceNat Genet199820178829731537
  • CorsiAXuTChenXDPhenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissuesJ Bone Miner Res20021771180118912102052
  • AmeyeLYoungMFMice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseasesGlycobiology2002129107R116R
  • ChenXDFisherLWRobeyPGYoungMFThe small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiationFaseb J200418994895815173106
  • CasarJCMcKechnieBAFallonJRYoungMFBrandanETransient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient miceDev Biol2004268235837115063173
  • BarnettMCollierGRCollierFMZimmetPO’DeaKA cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesusDiabetologia19943776716767958537
  • RahmaniMWongBWAngLVersican: signaling to transcriptional control pathwaysCan J Physiol Pharmacol2006841779216845893
  • AlbertsBBrayDLewisJRaffMRobertsKWatsonJDMolecular Biology of the Cell3rd edGarland Publishing1994
  • KresseHSchonherrEProteoglycans of the extracellular matrix and growth controlJ Cell Physiol2001189326627411748584
  • IozzoRVMurdochADProteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and functionFaseb J19961055986148621059
  • SmasCMSulHSControl of adipocyte differentiationBiochem J1995309Pt 36977107639681
  • HuberJLofflerMBilbanMPrevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acidsInt J Obes (Lond)20073161004101317130847
  • OlssonUBondjersGCamejoGFatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteinsDiabetes199948361662210078565
  • LehtiTMSilvennoinenMKivelaRKainulainenHKomulainenJEffects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscleAm J Physiol Endocrinol Metab20062905E90090716352670
  • KingVLHatchNWChanHWde BeerMCde BeerFCTannockLRA murine model of obesity with accelerated atherosclerosisObesity (Silver Spring)2010181354119498343
  • MangatRSuJScottPGRussellJCVineDFProctorSDChylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndromeBiochem Soc Trans200735Pt 347748117511632
  • ZhangWChuangYJJinTAntiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cellsCancer Res200666105047505516707426
  • WardMAjuwonKMRegulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorinCell Prolif201144434335121702857
  • MorethKBrodbeckRBabelovaAThe proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritisJ Clin Invest2010120124251427221084753
  • BabelovaAMorethKTsalastra-GreulWBiglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptorsJ Biol Chem200928436240352404819605353
  • SchaeferLBabelovaAKissEThe matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophagesJ Clin Invest200511582223223316025156
  • Torres-LealFLFonseca-AlanizMHRogeroMMTirapeguiJThe role of inflamed adipose tissue in the insulin resistanceCell Biochem Funct201028862363121104928
  • WellenKEHotamisligilGSInflammation, stress, and diabetesJ Clin Invest200511551111111915864338